Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.

JAMA dermatology - 1 Jul 2014

Valenzuela Antonia, Chung Lorinda, Casciola-Rosen Livia, Fiorentino David

Abstract excerpt

IMPORTANCE: Prior studies have estimated that up to 20% of adults with dermatomyositis (DM) have calcinosis, which can lead to significant morbidity. Identification of risk factors may provide a better understanding of the pathogenesis and ultimately therapy for this difficult clinical problem. R...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Calcinosis
Share to DEAD-box RNA Helicases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dermatomyositis

Share to Fingers

Share to Interferon-Induced Helicase, IFIH1

Share to Lung Diseases, Interstitial

Share to Ribonucleoproteins

Source

Open in PubMed Open full text

Identifiers

PMID: 24869801
DOI: 10.1001/jamadermatol.2013.10416
PMCID: PMC4351704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24869801-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.PMID 24869801Read ↗

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.Semantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Distinctive cutaneous and systemic features associated with specific antimyositis antibodies in adults with dermatomyositis: a prospective multicentric study of 117 patients.Semantic proximity Read ↗

The pathogenesis of dermatomyositis.Semantic proximity Read ↗

Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses.Semantic proximity Read ↗

Clinical phenotype and prognostic determinants of spontaneous pneumomediastinum in anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

Analysis of the Potential Link Between Dermatomyositis and CancerSemantic proximity Read ↗

Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.Semantic proximity Read ↗

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicrySemantic proximity Read ↗

Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis.Semantic proximity Read ↗

Adolescent-Onset Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Spontaneous Pneumomediastinum: A Case Report and Literature ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.